Related Experiment Video
Updated: Oct 9, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro
T Saeki1, A Mhashilkar, S Chada
1Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas, MD Anderson Cancer Center, TX 77030, USA.
Abstract:
The melanoma differentiation-associated gene-7 (mda-7), cloned from a human melanoma cell line H0-1, is known to induce tumor cell-selective growth inhibition in breast cancer cells in vitro and loss of tumorigenicity ex vivo. Yet, the mechanisms underlying these effects are still unknown. Therefore, we investigated these mechanisms on the molecular level in human non-small cell lung carcinoma (NSCLC) cells in vitro. Overexpression of mda-7 protein by Ad-mda-7 significantly suppressed proliferation and induced G2/M cell cycle arrest in wild-type p53 (A549, H460), and p53-null (H1299) non-small cell lung cancer cell lines, but not in normal human lung fibroblast (NHLF) cells. p53, Bax, and Bak protein expression was up-regulated in wild-type p53 tumor cell lines, but not in p53-null cells, suggesting that an intact p53 pathway was required for Bax and Bak induction. However, in all three cancer cell lines tested, activation of the caspase cascade and cleavage of poly(ADP-ribose) polymerase (PARP) appeared to be independent of the p53 mutational status. Together, these results suggest that apoptosis may be induced via multiple pathways by Ad-mda-7 in lung cancer cells and that Ad-mda-7 has the potential to become a novel therapeutic for clinical cancer gene therapy. Gene Therapy (2000) 7, 2051-2057.
Insights
Melanoma differentiation-associated gene-7 (mda-7) gene therapy suppressed non-small cell lung cancer (NSCLC) cell growth and induced cell cycle arrest. Apoptosis was triggered via p53-dependent and independent pathways, suggesting Ad-mda-7 as a novel cancer therapy.
Area of Science:
- Molecular biology
- Cancer research
- Gene therapy
Background:
- Melanoma differentiation-associated gene-7 (mda-7) inhibits tumor growth but its mechanisms are unknown.
- mda-7 was cloned from a human melanoma cell line.
Purpose of the Study:
- Investigate the molecular mechanisms of mda-7 in non-small cell lung carcinoma (NSCLC) cells.
- Determine the role of p53 in mda-7-induced effects.
Main Methods:
- Overexpression of mda-7 protein using Ad-mda-7 in NSCLC cell lines (wild-type p53 and p53-null) and normal lung fibroblasts.
- Analysis of cell proliferation, cell cycle arrest, and apoptosis-related protein expression (p53, Bax, Bak, caspase cascade, PARP).
Main Results:
- Ad-mda-7 suppressed proliferation and induced G2/M arrest in NSCLC cells, but not normal fibroblasts.
- p53, Bax, and Bak were upregulated in wild-type p53 cells, indicating p53 pathway involvement.
- Caspase activation and PARP cleavage were independent of p53 status, suggesting multiple apoptotic pathways.
Conclusions:
- Ad-mda-7 induces apoptosis in lung cancer cells through multiple pathways, irrespective of p53 status.
- Ad-mda-7 shows potential as a novel therapeutic agent for clinical cancer gene therapy.
